Mechanisms of disease

Metabolic effects of growth hormone and insulin-like growth factor 1

Derek LeRoith, Shoshana Yakar

Research output: Contribution to journalArticle

Abstract

Insulin-like growth factor (IGF) 1 is a member of a family that is involved in growth, development, cell differentiation, and metabolism. IGF1, IGF2 and insulin act primarily through tyrosine-kinase-linked receptors - the IGF1 receptor (IGF1R) and insulin receptor (IR). The IGF1R binds IGF1 and IGF2 with high affinity and the IR binds insulin with high affinity; however, since both receptors share a high degree of structural and functional homology, the IGF1R can bind insulin and the IR can bind the IGFs with reduced affinity. These two receptors can, moreover, form heterodimers, which bind both ligands. Upon binding to the receptors, cascades of tyrosine and serine kinases are stimulated to facilitate growth or metabolism. The IGF2 receptor is a scavenger receptor, and is, therefore, not involved in mediation of growth or metabolic effects of the IGF family and will not be discussed in the current article. IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development; however, IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid, and protein metabolism. For example, excess growth hormone causes insulin resistance and hyperglycemia, whereas IGF1 has insulin-like effects that reduce blood glucose levels and has been used experimentally to treat both type 1 and type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)302-310
Number of pages9
JournalNature Clinical Practice Endocrinology and Metabolism
Volume3
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Metabolic Diseases
Somatomedins
Growth Hormone
Insulin Receptor
Insulin
Growth and Development
Scavenger Receptors
Protein-Serine-Threonine Kinases
Receptor Protein-Tyrosine Kinases
Growth
Type 1 Diabetes Mellitus
Lipid Metabolism
Hyperglycemia
Protein-Tyrosine Kinases
Type 2 Diabetes Mellitus
Insulin Resistance
Blood Glucose
Cell Differentiation
Carbohydrates
Ligands

Keywords

  • Glucose homeostasis
  • Growth hormone
  • Insulin-like growth factor 1
  • Lipids
  • Protein

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Mechanisms of disease : Metabolic effects of growth hormone and insulin-like growth factor 1. / LeRoith, Derek; Yakar, Shoshana.

In: Nature Clinical Practice Endocrinology and Metabolism, Vol. 3, No. 3, 03.2007, p. 302-310.

Research output: Contribution to journalArticle

@article{e0e8cb528cfc433ca00d1451add5f4d5,
title = "Mechanisms of disease: Metabolic effects of growth hormone and insulin-like growth factor 1",
abstract = "Insulin-like growth factor (IGF) 1 is a member of a family that is involved in growth, development, cell differentiation, and metabolism. IGF1, IGF2 and insulin act primarily through tyrosine-kinase-linked receptors - the IGF1 receptor (IGF1R) and insulin receptor (IR). The IGF1R binds IGF1 and IGF2 with high affinity and the IR binds insulin with high affinity; however, since both receptors share a high degree of structural and functional homology, the IGF1R can bind insulin and the IR can bind the IGFs with reduced affinity. These two receptors can, moreover, form heterodimers, which bind both ligands. Upon binding to the receptors, cascades of tyrosine and serine kinases are stimulated to facilitate growth or metabolism. The IGF2 receptor is a scavenger receptor, and is, therefore, not involved in mediation of growth or metabolic effects of the IGF family and will not be discussed in the current article. IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development; however, IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid, and protein metabolism. For example, excess growth hormone causes insulin resistance and hyperglycemia, whereas IGF1 has insulin-like effects that reduce blood glucose levels and has been used experimentally to treat both type 1 and type 2 diabetes.",
keywords = "Glucose homeostasis, Growth hormone, Insulin-like growth factor 1, Lipids, Protein",
author = "Derek LeRoith and Shoshana Yakar",
year = "2007",
month = "3",
doi = "10.1038/ncpendmet0427",
language = "English (US)",
volume = "3",
pages = "302--310",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Mechanisms of disease

T2 - Metabolic effects of growth hormone and insulin-like growth factor 1

AU - LeRoith, Derek

AU - Yakar, Shoshana

PY - 2007/3

Y1 - 2007/3

N2 - Insulin-like growth factor (IGF) 1 is a member of a family that is involved in growth, development, cell differentiation, and metabolism. IGF1, IGF2 and insulin act primarily through tyrosine-kinase-linked receptors - the IGF1 receptor (IGF1R) and insulin receptor (IR). The IGF1R binds IGF1 and IGF2 with high affinity and the IR binds insulin with high affinity; however, since both receptors share a high degree of structural and functional homology, the IGF1R can bind insulin and the IR can bind the IGFs with reduced affinity. These two receptors can, moreover, form heterodimers, which bind both ligands. Upon binding to the receptors, cascades of tyrosine and serine kinases are stimulated to facilitate growth or metabolism. The IGF2 receptor is a scavenger receptor, and is, therefore, not involved in mediation of growth or metabolic effects of the IGF family and will not be discussed in the current article. IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development; however, IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid, and protein metabolism. For example, excess growth hormone causes insulin resistance and hyperglycemia, whereas IGF1 has insulin-like effects that reduce blood glucose levels and has been used experimentally to treat both type 1 and type 2 diabetes.

AB - Insulin-like growth factor (IGF) 1 is a member of a family that is involved in growth, development, cell differentiation, and metabolism. IGF1, IGF2 and insulin act primarily through tyrosine-kinase-linked receptors - the IGF1 receptor (IGF1R) and insulin receptor (IR). The IGF1R binds IGF1 and IGF2 with high affinity and the IR binds insulin with high affinity; however, since both receptors share a high degree of structural and functional homology, the IGF1R can bind insulin and the IR can bind the IGFs with reduced affinity. These two receptors can, moreover, form heterodimers, which bind both ligands. Upon binding to the receptors, cascades of tyrosine and serine kinases are stimulated to facilitate growth or metabolism. The IGF2 receptor is a scavenger receptor, and is, therefore, not involved in mediation of growth or metabolic effects of the IGF family and will not be discussed in the current article. IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development; however, IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid, and protein metabolism. For example, excess growth hormone causes insulin resistance and hyperglycemia, whereas IGF1 has insulin-like effects that reduce blood glucose levels and has been used experimentally to treat both type 1 and type 2 diabetes.

KW - Glucose homeostasis

KW - Growth hormone

KW - Insulin-like growth factor 1

KW - Lipids

KW - Protein

UR - http://www.scopus.com/inward/record.url?scp=33847221165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847221165&partnerID=8YFLogxK

U2 - 10.1038/ncpendmet0427

DO - 10.1038/ncpendmet0427

M3 - Article

VL - 3

SP - 302

EP - 310

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 3

ER -